Mighty microglia

How microglia-specific therapies may be safer for brain cancer patients

Microglia-specific therapies could be a safer option for brain cancer patients than those that recruit macrophages, according to a paper published this month in Proceedings of the National Academy of Sciences.

While the Stanford University and Colorado University authors had shown in a 2017

Read the full 430 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE